Vienna, Austria

Hans Loibner

USPTO Granted Patents = 32 

 

 

Average Co-Inventor Count = 3.2

ph-index = 5

Forward Citations = 105(Granted Patents)


Company Filing History:


Years Active: 1985-2023

Loading Chart...
Loading Chart...
Loading Chart...
32 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Hans Loibner in Cancer Treatment

Introduction

Hans Loibner, an accomplished inventor based in Vienna, Austria, has made significant strides in the field of cancer treatment through his remarkable innovations. With a portfolio of 32 patents to his name, Loibner's work focuses on developing novel therapies aimed at combating GD2 positive cancers, particularly high-risk neuroblastoma.

Latest Patents

One of Loibner's most notable inventions involves preparations and methods for treating GD2 positive cancer by administering a chimeric or humanized anti-GD2 antibody to patients. This method emphasizes the administration of the antibody without concomitant treatment with Interleukin-2 (IL-2). Additionally, his research highlights continuous infusion strategies of anti-GD2 antibodies and explores the involvement of retinoid treatments during various stages of therapy.

Career Highlights

His career has seen significant affiliations with leading firms like Apeiron Biologics AG and Sandoz GmbH. These roles have allowed him to push the boundaries of cancer treatment, contribute to the development of pioneering therapies, and actively participate in clinical advancements within the biotechnology field.

Collaborations

Throughout his journey, Hans Loibner has collaborated with esteemed colleagues, including Manfred Schuster and Oliver Mutschlechner. These partnerships have played a crucial role in enhancing his research and expanding the impact of his innovative approaches to cancer therapy.

Conclusion

Hans Loibner's commitment to advancing cancer treatment through innovative inventions underscores the vital role of inventors in medicine. His work not only highlights the significance of targeted therapies but also reflects a dedication to improving patient outcomes. With numerous patents and collaborations to his credit, Loibner continues to be a pivotal figure in the medical research landscape.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…